Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07649031 · ClinicalTrials.gov registry record
MRI as Noninvasive Innovative Approach in Detection and Monitoring of Malignant Oral Lesions in Fanconi Anemia Patients
A clinical trial, sponsored by University of Minnesota.
- Recruiting
- Registry status
- 80
- Enrollment target
NCT07649031: Recruiting study, sponsored by University of Minnesota.
NCT07649031 is a clinical trial that is actively recruiting participants, run by University of Minnesota. The registered enrollment target is 80 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07649031 is actively recruiting participants, sponsored by University of Minnesota.
- RECRUITING
- Registry status
- 80 participants
- Enrollment target
Study Summary
This study being done to learn more about the use of medical Magnetic Resonance Imaging (mMRI) and dedicated dental MRI (ddMRI) as a non-invasive diagnosing tool when evaluating potential oral cancerous and precancerous lesions in Fanconi Anemia patients.
Primary Outcome
Proportion of positive lesions correctly diagnosed
Interventions
- DIAGNOSTIC_TEST MRIs
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2026-06-23 |
| Est. Completion | 2030-05-31 |
What NCT07649031 shows while recruiting
NCT07649031 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 80 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which MRIs is the first listed.
NCT07649031 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07649031 about?
NCT07649031 is a clinical study titled "MRI as Noninvasive Innovative Approach in Detection and Monitoring of Malignant Oral Lesions in Fanconi Anemia Patients". This study being done to learn more about the use of medical Magnetic Resonance Imaging (mMRI) and dedicated dental MRI (ddMRI) as a non-invasive diagnosing tool when evaluating potential oral cancerous and precancerous lesions in Fanconi Anemia patients.
What is the current status of trial NCT07649031?
This trial is currently recruiting. The enrollment target is 80 participants. The study started on 2026-06-23. Estimated completion is 2030-05-31.
What interventions are being tested in trial NCT07649031?
The interventions under investigation include: MRIs (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT07649031?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI